You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 9 No. 1, July 1963 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Sensitivity to Succinylcholine

Biochemical and Clinical Studies

T. GEORGE BIDDER, MD; ALBERT SATTIN, MD; A. SCOTT DOWLING, MD

Arch Gen Psychiatry. 1963;9(1):96-101.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Introduction

More succinylcholine (SDC)* is used today by psychiatrists than by any other group of physicians except anesthesiologists. It has been established that SDC modification of electroconvulsive therapy (ECT) reduces the intensity of the cardiovascular strain and the incidence of bone fractures and hypoxia ordinarily associated with this procedure.1,2 A major advantage that has accrued from the reduction of these troublesome complications is the increased use of ECT with older and poor-risk patients for whom it was previously contraindicated. In addition, the relaxed SDC-treated patient is easily oxygenated by bag breathing which reduces the danger of hypoxia, a potential cause of brain damage and cardiac arrest.

In spite of the widespread acceptance of SDC modification, some psychiatrists prefer, in many cases, to give ECT without this muscle relaxant.3,4 The mortality rate with unmodified ECT has been consistently low (0.08% or less) despite an equally consistent, but disturbing, . . . [Full Text PDF of this Article]


Author Affiliations

CLEVELAND

From the Division of Psychiatry, Department of Medicine, University Hospitals of Cleveland, and Western Reserve University School of Medicine.

Associate Professor of Medicine and Pharmacology in the Division of Psychiatry, University Hospitals of Cleveland and Western Reserve University School of Medicine (Dr. Bidder); Teaching Fellow in Psychiatry, Western Reserve University School of Medicine (Dr. Sattin); Fellow in Child Psychiatry, Western Reserve University School of Medicine (Dr. Dowling).


Footnotes

Submitted for publication Oct 19, 1962.

Succinyldicholine (Anectine, Scoline, Quelicin).

Presented at the 1961 Annual Meeting of the American Psychiatric Association, Chicago, May 8, 1961.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1963 American Medical Association. All Rights Reserved.